Inventor
YOCCA FRANK
US19 patents
⚠️ This page may combine multiple inventors who share the name “YOCCA FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOXCEL THERAPEUTICS INC
17 patentsUS11559484B2Jan 24, 2023
Film formulations containing dexmedetomidine and methods of producing them
BIOXCEL THERAPEUTICS INC11 citations93
US10792246B2Oct 6, 2020
Film formulations containing dexmedetomidine and methods of producing them
BIOXCEL THERAPEUTICS INC19 citations93
US11806334B1Nov 7, 2023
Non-sedating dexmedetomidine treatment regimens
BIOXCEL THERAPEUTICS INC4 citations84
US11806429B2Nov 7, 2023
Film formulations containing dexmedetomidine and methods of producing them
BIOXCEL THERAPEUTICS INC4 citations84
US11517524B2Dec 6, 2022
Film formulations containing dexmedetomidine and methods of producing them
BIOXCEL THERAPEUTICS INC9 citations84
US11497711B2Nov 15, 2022
Film formulations containing dexmedetomidine and methods of producing them
BIOXCEL THERAPEUTICS INC9 citations84
US11478422B2Oct 25, 2022
Film formulations containing dexmedetomidine and methods of producing them
BIOXCEL THERAPEUTICS INC10 citations84
US12109196B2Oct 8, 2024
Non-sedating dexmedetomidine treatment regimens
BIOXCEL THERAPEUTICS INC1 citations71
US11998529B2Jun 4, 2024
Non-sedating dexmedetomidine treatment regimens
BIOXCEL THERAPEUTICS INC1 citations71
US11890272B2Feb 6, 2024
Non-sedating dexmedetomidine treatment regimens
BIOXCEL THERAPEUTICS INC1 citations71
US11786508B2Oct 17, 2023
Use of sublingual dexmedetomidine for the treatment of agitation
BIOXCEL THERAPEUTICS INC4 citations71
US11839604B2Dec 12, 2023
Use of sublingual dexmedetomidine for the treatment of agitation
BIOXCEL THERAPEUTICS INC2 citations70
US12364683B2Jul 22, 2025
Non-sedating dexmedetomidine treatment regimens
BIOXCEL THERAPEUTICS INC0 citations61
US12138247B2Nov 12, 2024
Non-sedating dexmedetomidine treatment regimens
BIOXCEL THERAPEUTICS INC0 citations61
US12090140B2Sep 17, 2024
Non-sedating dexmedetomidine treatment regimens
BIOXCEL THERAPEUTICS INC0 citations61
US11998528B1Jun 4, 2024
Non-sedating dexmedetomidine treatment regimens
BIOXCEL THERAPEUTICS INC0 citations61
US11931340B2Mar 19, 2024
Use of sublingual dexmedetomidine for the treatment of agitation
BIOXCEL THERAPEUTICS INC0 citations59